BAL, E. Et Al. 2022. Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy. ECRD-2022 (11th European Conference on Rare Diseases & Orphan Products) , (France).

BAL, E., Yelgen, G., Odabaş, S. P., & TAŞTAN, C., (2022). Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy . ECRD-2022 (11th European Conference on Rare Diseases & Orphan Products), France

BAL, ENES Et Al. "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy," ECRD-2022 (11th European Conference on Rare Diseases & Orphan Products), France, 2022

BAL, ENES Et Al. "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy." ECRD-2022 (11th European Conference on Rare Diseases & Orphan Products) , France, 2022

BAL, E. Et Al. (2022) . "Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy." ECRD-2022 (11th European Conference on Rare Diseases & Orphan Products) , France.

@conferencepaper{conferencepaper, author={ENES BAL Et Al. }, title={Exon7 Targeted CRISPR-Prime Editing Approaches for SMN2 Gene Editing in Spinal Muscular Atrophy}, congress name={ECRD-2022 (11th European Conference on Rare Diseases & Orphan Products)}, city={}, country={France}, year={2022}}